Skip to main content
Premium Trial:

Request an Annual Quote

Finland s Chip-Man Raises 1.4M Euro to Develop Cell-Analysis Platform

NEW YORK, March 21 (GenomeWeb News) - Chip-Man Technologies, a Tampere, Finland-based developer of cellular analysis technology, said today that it has secured €1.4 million in first-round financing.


The company will use the funding, provided by Aura Capital and Finnish Industry Investment, to further develop its Cell-IQ cell analysis platform.


The company's Cell-IQ system monitors morphological and physiological changes in cell lines, primary cells, co-cultures, and monolayer tissue models in real time.


Chip-Man said that the market for automated cell analysis tools in pharmaceutical and medical research is estimated at around $500 million and is growing at 30 percent annually.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more